Heterogeneity in major depressive disorder: the need for biomarker-based personalized treatments

S Suseelan, G Pinna - Advances in Clinical Chemistry, 2023 - Elsevier
Abstract Major Depressive Disorder (MDD) or depression is a pathological mental condition
affecting millions of people worldwide. Identification of objective biological markers of …

Fibroblast growth factors in depression

Z Deng, S Deng, MR Zhang, MM Tang - Frontiers in pharmacology, 2019 - frontiersin.org
Major depressive disorder (MDD) is one of the most serious diseases and now becomes a
major public health problem in the world. The pathogenesis of depression remains poorly …

The association between salivary FGF2 and physiological and psychological components of the human stress response

EM Bryant, R Richardson, BM Graham - Chronic Stress, 2022 - journals.sagepub.com
Background Fibroblast Growth Factor 2 (FGF2) is a neurotrophic protein that has been
implicated as a biomarker for anxiety and depressive disorders, which comprise a significant …

Natural products for the treatment of depression: Insights into signal pathways influencing the hypothalamic–pituitary–adrenal axis

J Liu, T Meng, C Wang, W Cheng, Q Zhang, G Cheng - Medicine, 2023 - journals.lww.com
Depression, a prevalent psychiatric malady, afflicts a substantial global demographic,
engendering considerable disease burden due to its elevated morbidity and mortality rates …

An Interaction between Brain-Derived Neurotrophic Factor and Stress-Related Glucocorticoids in the Pathophysiology of Alzheimer's Disease

T Numakawa, R Kajihara - International Journal of Molecular Sciences, 2024 - mdpi.com
Both the brain-derived neurotrophic factor (BDNF) and glucocorticoids (GCs) play multiple
roles in various aspects of neurons, including cell survival and synaptic function. BDNF and …

Glucocorticoids induce HMGB1 release in primary cultured rat cortical microglia

K Hisaoka-Nakashima, Y Takeuchi, Y Saito, T Shimoda… - Neuroscience, 2024 - Elsevier
Stress, a risk factor for major depressive disorder and Alzheimer disease, leads to the
release of high-mobility group box-1 (HMGB1) protein, which in turn causes …

Enhanced social reward response and anxiety-like behavior with downregulation of nucleus accumbens glucocorticoid receptor in BALB/c mice

S Chiba, T Numakawa, T Murata… - Journal of Veterinary …, 2023 - jstage.jst.go.jp
Social anhedonia is a psychological state with difficulty in experiencing pleasure from social
interactions and is observed in various diseases, such as depressive disorders. Although …

Abnormalities in FGF family members and their roles in modulating depression‐related molecules

YH Xu, Y Zhu, YY Zhu, H Wei, NN Zhang… - European Journal of …, 2021 - Wiley Online Library
The role of the fibroblast growth factor (FGF) system in depression has received
considerable attention in recent years. To understand the role of this system, it is important to …

[HTML][HTML] 成纤维细胞生长因子在中枢神经系统疾病中的作用

W HUANG, QIU Wanhua, C Kun… - Journal of Zhejiang …, 2022 - ncbi.nlm.nih.gov
成纤维细胞生长因子( FGF) 是一组家族性结构相关的蛋白多肽, 与其受体构成了一个复杂的
信号系统。 近年来, 越来越多证据表明FGF 家族在中枢神经系统损伤修复中起到关键作用 …

An Interaction among Neurotrophic Factor BDNF and Stress-Related Glucocorticoids in the Pathophysiology of Alzheimer's Disease

T Numakawa, R Kajihara - 2023 - preprints.org
Both brain-derived neurotrophic factor (BDNF) and glucocorticoids (GCs) have multiple roles
in the various aspects of neurons, including cell survival and synaptic function. BDNF and its …